Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Agreement Between Serum Assays Performed in ED Point-of-Care and Hospital Central Laboratories.

Dashevsky M, Bernstein SL, Barsky CL, Taylor RA.

West J Emerg Med. 2017 Apr;18(3):403-409. doi: 10.5811/westjem.2017.1.30532. Epub 2017 Mar 13.

2.

Electrically tunable organic-inorganic hybrid polaritons with monolayer WS2.

Flatten LC, Coles DM, He Z, Lidzey DG, Taylor RA, Warner JH, Smith JM.

Nat Commun. 2017 Jan 17;8:14097. doi: 10.1038/ncomms14097.

3.

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.

Taylor RA, Fraser M, Livingstone J, Espiritu SM, Thorne H, Huang V, Lo W, Shiah YJ, Yamaguchi TN, Sliwinski A, Horsburgh S, Meng A, Heisler LE, Yu N, Yousif F, Papargiris M, Lawrence MG, Timms L, Murphy DG, Frydenberg M, Hopkins JF, Bolton D, Clouston D, McPherson JD, van der Kwast T, Boutros PC, Risbridger GP, Bristow RG.

Nat Commun. 2017 Jan 9;8:13671. doi: 10.1038/ncomms13671.

4.

Quasi-one-dimensional density of states in a single quantum ring.

Kim H, Lee W, Park S, Kyhm K, Je K, Taylor RA, Nogues G, Dang LS, Song JD.

Sci Rep. 2017 Jan 5;7:40026. doi: 10.1038/srep40026.

5.

TGF-β1 modulates microglial phenotype and promotes recovery after intracerebral hemorrhage.

Taylor RA, Chang CF, Goods BA, Hammond MD, Mac Grory B, Ai Y, Steinschneider AF, Renfroe SC, Askenase MH, McCullough LD, Kasner SE, Mullen MT, Hafler DA, Love JC, Sansing LH.

J Clin Invest. 2017 Jan 3;127(1):280-292. doi: 10.1172/JCI88647. Epub 2016 Nov 28.

6.

Quantum dot-like excitonic behavior in individual single walled-carbon nanotubes.

Wang X, Alexander-Webber JA, Jia W, Reid BP, Stranks SD, Holmes MJ, Chan CC, Deng C, Nicholas RJ, Taylor RA.

Sci Rep. 2016 Nov 16;6:37167. doi: 10.1038/srep37167.

7.

Mathematical models are a powerful method to understand and control the spread of Huanglongbing.

Taylor RA, Mordecai EA, Gilligan CA, Rohr JR, Johnson LR.

PeerJ. 2016 Nov 3;4:e2642. eCollection 2016.

8.

Room-temperature exciton-polaritons with two-dimensional WS2.

Flatten LC, He Z, Coles DM, Trichet AA, Powell AW, Taylor RA, Warner JH, Smith JM.

Sci Rep. 2016 Sep 19;6:33134. doi: 10.1038/srep33134.

9.

A single nucleotide polymorphism genotyping platform for the authentication of patient derived xenografts.

El-Hoss J, Jing D, Evans K, Toscan C, Xie J, Lee H, Taylor RA, Lawrence MG, Risbridger GP, MacKenzie KL, Sutton R, Lock RB.

Oncotarget. 2016 Sep 13;7(37):60475-60490. doi: 10.18632/oncotarget.11125.

10.

Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.

Lo JC, Clark AK, Ascui N, Frydenberg M, Risbridger GP, Taylor RA, Watt MJ.

Oncotarget. 2016 Jul 26;7(30):47650-47662. doi: 10.18632/oncotarget.10258.

11.

Carrier trapping and confinement in Ge nanocrystals surrounded by Ge3N4.

Park Y, Chan CC, Reid BP, Nuttall L, Taylor RA, Lee NS, Lee YM.

Sci Rep. 2016 May 5;6:25449. doi: 10.1038/srep25449.

12.

Linking obesogenic dysregulation to prostate cancer progression.

Taylor RA, Lo J, Ascui N, Watt MJ.

Endocr Connect. 2015 Dec;4(4):R68-80. doi: 10.1530/EC-15-0080. Review.

13.

Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G.

Oncotarget. 2015 Nov 3;6(34):36923. doi: 10.18632/oncotarget.6263. No abstract available.

14.

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G.

Oncotarget. 2015 Jun 30;6(18):16135-50. Erratum in: Oncotarget. 2015 Nov 3;6(34):36923. Palenthorpe, Helen M [Corrected to Palethorpe, Helen M].

15.

CX3CR1 signaling on monocytes is dispensable after intracerebral hemorrhage.

Taylor RA, Hammond MD, Ai Y, Sansing LH.

PLoS One. 2014 Dec 3;9(12):e114472. doi: 10.1371/journal.pone.0114472. eCollection 2014.

16.

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity.

Takizawa I, Lawrence MG, Balanathan P, Rebello R, Pearson HB, Garg E, Pedersen J, Pouliot N, Nadon R, Watt MJ, Taylor RA, Humbert P, Topisirovic I, Larsson O, Risbridger GP, Furic L.

Oncotarget. 2015 Jan 20;6(2):604-16.

17.

CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.

Hammond MD, Taylor RA, Mullen MT, Ai Y, Aguila HL, Mack M, Kasner SE, McCullough LD, Sansing LH.

J Neurosci. 2014 Mar 12;34(11):3901-9. doi: 10.1523/JNEUROSCI.4070-13.2014.

18.

Manufacturing and wetting low-cost microfluidic cell separation devices.

Pawell RS, Inglis DW, Barber TJ, Taylor RA.

Biomicrofluidics. 2013 Sep 11;7(5):56501. doi: 10.1063/1.4821315. eCollection 2013.

19.

Use of intravenous recombinant tissue plasminogen activator in patients with borderline elevation of international normalized ratio.

Aggarwal HR, Hassan AE, Rodriguez GJ, Suri MF, Taylor RA, Qureshi AI.

J Vasc Interv Neurol. 2013 Dec;6(2):1-8.

20.

Microglial responses after ischemic stroke and intracerebral hemorrhage.

Taylor RA, Sansing LH.

Clin Dev Immunol. 2013;2013:746068. doi: 10.1155/2013/746068. Epub 2013 Oct 10. Review.

Supplemental Content

Loading ...
Support Center